COMMUNIQUÉS West-GlobeNewswire

IRIDEX to Report Fourth Quarter and 2018 Financial Results on March 5, 2019
26/02/2019
MOUNTAIN VIEW, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading [...]
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
26/02/2019
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access [...]
MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call
26/02/2019
Conference Call to Begin Today at 9:00 AM ET 4Q 2018 Total Revenues were $16.0 million; 254% growth vs. 4Q 2017 4Q 2018 Afrezza Net Revenue was $5.7 million; 28% growth vs. 4Q 2017 on a GAAP basis and 86% when adjusted [...]
VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)
26/02/2019
TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), (the “Company”) today announced new data implicating the potential of its VB-600 platform of antibodies targeting MOSPD2 (motile [...]
Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy
26/02/2019
AVA-101 designed to enhance efficacy and overcome safety challenges of current CAR-T immune-oncology therapeutics AVA-101 represents a first-in-class transposon-based Chimeric Antigen Receptor (CAR) system targeting [...]
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019
26/02/2019
MIAMI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and twelve months ended December 31, 2018 as well as provide guidance on [...]
Centura Health Joins Innovative Movement for One-Stick Hospitalization
26/02/2019
Partners with Fast Company’s Most Innovative Company recipient, Velano Vascular, to deliver PIVO to inpatients in Colorado and Kansas ENGLEWOOD, Colo., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Centura Health, the region’s [...]
Philips introduces IntelliSpace Portal 11 at ECR 2019 to support diagnostic confidence
26/02/2019
February 26, 2019 Latest release of Philips advanced visualization platform continues to build on innovations in intelligent clinical applications, hospital network connectivity, and patient data security Amsterdam, the [...]
Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting
26/02/2019
MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference
26/02/2019
BRISBANE, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Inhibikase Therapeutics Files Two Investigational New Drug Applications for IkT-148009, a Disease-Modifying Therapy for Parkinson’s Disease
26/02/2019
ATLANTA and BOSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases [...]
BioTime to Present New Data From OpRegen® and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019)
26/02/2019
ALAMEDA, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that updated results from a Phase I/IIa [...]
electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark
26/02/2019
BASKING RIDGE, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Highmark, one of the nation’s top health insurers and the [...]
Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting
26/02/2019
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR720
26/02/2019
Phase 1 top-line data readout for oral SPR720 expected in second half of 2019 CAMBRIDGE, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical [...]
Ceapro Inc. Announces Three Abstracts Selected for Oral Presentation at the 17th European Meeting on Supercritical Fluids (EMSF 2019)
26/02/2019
- Important research findings from collaboration with University of Alberta demonstrating potential of Ceapro’s unique enabling PGX technology to produce innovative delivery systems - EDMONTON, Alberta, Feb. 26, 2019 ( [...]
Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019
26/02/2019
DURHAM, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a [...]
Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
26/02/2019
Groundbreaking pediatric non-verbal disorder treatment QBM-001 presented to over 30,000 drug discovery professionals through print edition of DDN News NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( QBIO ), [...]
BioSig Announces Expansion of Engineering Team
26/02/2019
New hires to drive R&D and manufacturing efforts Santa Monica, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal [...]

Pages